Good morning :)
$
₹
A

ABIVAX Société Anonyme

ABVX

PINK
$86.901.41% (-1.24)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Biotechnology

Mid Cap

With a market cap of $7.7B the stock is ranked 1124

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

19.53
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-6.02
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

0%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 12 analysts reports

Buy
12 analysts
Hold
0 analyst
Sell
0 analyst

Price Upside

+86.05%

Earnings Growth

+22.76%

Rev. Growth

—

See Detailed Forecast

Company Profile

Company Profile

P/E Ratio
78.09
78.09
1Y Return
20.91%
20.91%
Buy Reco %
80.00
80.00
P/E Ratio
25.76
25.76
1Y Return
42.89%
42.89%
Buy Reco %
35.29
35.29
P/E Ratio
—
—
1Y Return
27.25%
27.25%
Buy Reco %
78.57
78.57
P/E Ratio
29.70
29.70
1Y Return
24.45%
24.45%
Buy Reco %
81.25
81.25
P/E Ratio
—
—
1Y Return
699.32%
699.32%
Buy Reco %
21.73
21.73
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Financials

Financials

Income

Balance Sheet

Cash Flow

-153.3
-2
-287.6
-48.4
-117.4
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue03.3907.3902.010-2.0100
Net Income-42.86-38.77-55.22-52.37-52.37-48.41-153.35-287.68-48.46-117.43
Net Profit Margin--1142.67%--707.79%--2400.29%-14263.16%--

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareBiotechnology
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
ABIVAX Société Anonyme -19.53-
AbbVie Inc78.0950.450.54
Amgen Inc25.7618.782.45

Price Comparison

Price Comparison

Compare ABVX with any stock or ETF
Compare ABVX with any stock or ETF
Comparing from
ABVX
ABBV
AMGN
Loading...

Frequently asked questions

  1. ABIVAX Société Anonyme (ABVX) share price today is $86.90 as of October 13, 2026 at 1:30 AM IST. The stock touched a day high of $87.79 and a day low of $86.46.

  2. ABIVAX Société Anonyme stock trades on PINK under the ticker symbol ABVX.

  3. ABIVAX Société Anonyme's market capitalization is $7.69B as of October 13, 2026 at 1:30 AM IST.

  4. ABIVAX Société Anonyme's price-to-earnings (P/E) ratio is N/A as of October 12, 2026.

  5. ABIVAX Société Anonyme's price-to-book (P/B) ratio is 19.53 as of October 12, 2026.

  6. Yes, You can buy ABIVAX Société Anonyme shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy ABIVAX Société Anonyme shares in three steps: 1. Search ABIVAX Société Anonyme on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since ABIVAX Société Anonyme trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in ABIVAX Société Anonyme (ABVX) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.115 shares at the current price of $86.90.

Loading...